Lipid-mediated delivery of oligonucleotide to pulmonary endothelium

American Journal of Respiratory Cell and Molecular Biology

Volumn 27, Issue 2, 2002, Pages 151-159

  Ma, Zheng ^a   Zhang, Junlan ^a   Alber, Sean ^a   Dileo, John ^a   Negishi, Yoichi ^a   Stolz, Donna ^a   Watkins, Simon ^a   Huang, Leaf ^a   Pitt, Bruce ^a   Li, Song ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIOLEOYLOXY 3 (TRIMETHYLAMMONIUM)PROPANE; 1,2-DIOLEOYLOXY-3-(TRIMETHYLAMMONIUM)PROPANE; ANTISENSE OLIGODEOXYNUCLEOTIDE; ENDOTOXIN; ENDOTOXIN, ESCHERICHIA COLI; FLUORESCENT DYE; INTERCELLULAR ADHESION MOLECULE 1; LIPOSOME; MONOUNSATURATED FATTY ACID; QUATERNARY AMMONIUM DERIVATIVE;

ANIMAL; ARTICLE; CHEMISTRY; DRUG EFFECT; ENDOTHELIUM; FEMALE; GENE TRANSFER; GENE VECTOR; GENETICS; LUNG; METABOLISM; MOUSE; ULTRASTRUCTURE;

ANIMALS; ENDOTHELIUM; ENDOTOXINS; FATTY ACIDS, MONOUNSATURATED; FEMALE; FLUORESCENT DYES; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; INTERCELLULAR ADHESION MOLECULE-1; LIPOSOMES; LUNG; MICE; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; QUATERNARY AMMONIUM COMPOUNDS;

EID: 0035984573     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.27.2.4653     Document Type: Article

References (33)

1. Endothelial dysfunction in the pulmonary vascular bed
2. Role of endothelial and smooth muscle cells in the physiopathology and treatment management of pulmonary hypertension
3. Molecular mechanisms of action of antisense drugs
4. Antisense oligonucleotides as a tool for gene functionalization and target validation
5. Antisense peptide nucleic acids
6. Mixed backbone oligonucleotides: Improvement in oligonucleotide-induced toxicity in vivo
7. Antisense oligonucleotides targeting the epidermal growth factor receptor inhibit proliferation, induce apoptosis, and cooperate with cytotoxic drugs in human cancer cell lines
8. Iodo-Gen-mediated radioiodination of nucleic acids
9. Pulmonary edema
10. Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery
11. Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery
12. Characterization of cationic liposome-mediated gene transfer in vivo by intravenous administration
13. Effect of immune response on gene transfer to the lung via systemic administration of cationic lipidic vectors
14. Reduced inflammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs
15. Immunostimulatory DNA: Sequence-dependent production of potentially harmful or useful cytokines
16. Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in mice
17. Comprehensive analysis of the acute toxicities induced by systemic administration of cationic lipid:plasmid DNA complexes in mice
18. Effects of complement depletion on the pharmacokinetics and gene delivery mediated by cationic lipid-DNA complexes
19. In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes
20. Improved DNA: Liposome complexes for increased systemic delivery and gene expression
21. Evidence for the role of proteoglycans in cation-mediated gene transfer
22. Proteoglycans mediate cationic liposome-DNA complex-based gene delivery in vitro and in vivo
23. Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: Implications for intravenous lipofection
24. Phosphatidylethanolamine liposomes: Drug delivery, gene transfer and immunodiagnostic applications
25. Fate of cationic liposomes and their complex with oligonucleotide in vivo
26. Cationic lipids enhance cytokine and cell influx levels in the lung following administration of plasmid: Cationic lipid complexes
27. The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo
28. Systemic administration of LPD prepared with CpG oligonucleotides inhibits the growth of established pulmonary metastases by stimulating innate and acquired anti-tumor immune responses
29. Targeted gene delivery to pulmonary endothelium by anti-PECAM antibody
30. Two problems in antisense biotechnology: In vitro delivery and the design of antisense experiments
31. Blocking of heart allograft rejection by intercellular adhesion molecule-1 antisense oligonucleotides alone or in combination with other immunosuppressive modalities
32. Role of the intercellular adhesion molecule-1(ICAM-1) in endotoxin-induced pneumonia evaluated using ICAM-1 antisense oligonucleotides, anti-ICAM-1 monoclonal antibodies, and ICAM-1 mutant mice
33. Aspects of the transport and delivery of antisense oligonucleotides